Review of once-monthly oral ibandronate and the use thereof

South African Family Practice

 
 
Field Value
 
Title Review of once-monthly oral ibandronate and the use thereof
 
Creator De Villiers, T Davey, M Cassim, B De Lange, W
 
Subject — oral ibandronate
Description An advisory board meeting of key opinion leaders was held in 2015 to discuss the clinical data on oral ibandronate in the treatment of postmenopausal osteoporosis.

Boniva 150 mg (ibandronate) oral once-monthly is indicated for the treatment of osteoporosis in postmenopausal women, in order to reduce the risk of vertebral fractures.1
 
Publisher AOSIS
 
Contributor
Date 2017-08-28
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article —
Format application/pdf
Identifier 10.4102/safp.v59i4.4728
 
Source South African Family Practice; Vol 59, No 4 (2017): July/August; 32-35 2078-6204 2078-6190
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://safpj.co.za/index.php/safpj/article/view/4728/5620
 
Coverage — — —
ADVERTISEMENT